AgeX Therapeutics, Inc. (NYSE:AGE – Get Rating)’s share price was down 7.3% on Monday . The company traded as low as $0.52 and last traded at $0.52. Approximately 92,505 shares changed hands during trading, an increase of 351% from the average daily volume of 20,491 shares. The stock had previously closed at $0.56.
AgeX Therapeutics Price Performance
The company has a market cap of $19.74 million, a P/E ratio of -1.79 and a beta of 1.50. The stock’s 50-day moving average is $0.61 and its two-hundred day moving average is $0.62.
AgeX Therapeutics (NYSE:AGE – Get Rating) last issued its quarterly earnings data on Friday, March 31st. The company reported ($0.07) earnings per share for the quarter. The company had revenue of $0.01 million for the quarter.
Institutional Inflows and Outflows
About AgeX Therapeutics
AgeX Therapeutics, Inc operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.
- Get a free copy of the StockNews.com research report on AgeX Therapeutics (AGE)
- monday.com Surges on Price and Volume after Blowout Results
- Can Ryanair Stock Fly Above Resistance Levels, What Earnings Show
- All Aboard! The Sell-Side Has Railroads In Reversal
- Is There Value Left in Lyft Stock?
- Everything About ZIM Integrated Screams Undervaluation
Receive News & Ratings for AgeX Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AgeX Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.